JLK Inc
KOSDAQ:322510
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
JLK Inc
Stock-Based Compensation
JLK Inc
Stock-Based Compensation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
JLK Inc
KOSDAQ:322510
|
Stock-Based Compensation
₩893.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
I
|
Infinitt Healthcare Co Ltd
KOSDAQ:071200
|
Stock-Based Compensation
₩259.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-9%
|
|
|
U
|
UBCare Co Ltd
KOSDAQ:032620
|
Stock-Based Compensation
₩72m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
|
L
|
LifeSemantics Corp
KOSDAQ:347700
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
e
|
ezCaretech Co Ltd
KOSDAQ:099750
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
L
|
Lunit Inc
KOSDAQ:328130
|
Stock-Based Compensation
₩9.8B
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
JLK Inc
Glance View
JLK, Inc. develops AI based data-driven diagnostic system that detects brain disease. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2019-12-11. The firm develops software including AI medical analysis solutions, AI industry and security analysis solutions and others. Medical diagnostic platforms consist of AI medical systems, AI quantitative analysis platforms, AI remote platforms, AI medical diagnostic platforms, among others.
See Also
What is JLK Inc's Stock-Based Compensation?
Stock-Based Compensation
893.3m
KRW
Based on the financial report for Sep 30, 2025, JLK Inc's Stock-Based Compensation amounts to 893.3m KRW.
What is JLK Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
-19%
Over the last year, the Stock-Based Compensation growth was -67%.
